Ketkar Manasi, Sahoo Niroj, Raval Vishal
Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, India .
Retin Cases Brief Rep. 2025 Mar 1;19(2):210-213. doi: 10.1097/ICB.0000000000001551.
The aim of this study was to report a case of primary vitreoretinal lymphoma (PVRL) relapse presenting as occlusive retinal vasculitis with secondary neovascularization.
This study was a retrospective case report.
A 40-year-old woman presented to the clinic with complaints of blurring of vision in the left eye for 4 months. Her best-corrected VA (BCVA) was 20/20 and 20/500 in the right and left eye, respectively. The vitreous cavities of both eyes showed vitreous opacities (2+). Both eyes fundus showed multifocal yellowish-white subretinal infiltration. A diagnostic vitreous and subretinal biopsy of the left eye revealed large lymphoid cells with CD-20 positivity, confirming the diagnosis of PVRL. The patient received 12 intravitreal methotrexate injections in both eyes over a course of 2 months, after which the lesions completely resolved. However, after 5 months, the left eye showed characteristic subretinal lesions along with perivascular exudates and retinal hemorrhages, diagnosed as PVRL relapse presenting as occlusive retinal vasculitis. Fluorescein angiography revealed retinal neovascularization, for which panretinal photocoagulation was performed along with repeated intravitreal methotrexate injections.
Primary vitreoretinal lymphoma is a great masquerader, and although rare, PVRL relapse can present as occlusive retinal vasculitis with secondary neovascularization, thereby delaying diagnosis and subsequent treatment.
本研究旨在报告一例原发性玻璃体视网膜淋巴瘤(PVRL)复发,表现为闭塞性视网膜血管炎伴继发性新生血管形成。
本研究为回顾性病例报告。
一名40岁女性因左眼视力模糊4个月就诊。她的最佳矫正视力(BCVA)右眼为20/20,左眼为20/500。双眼玻璃体腔均显示玻璃体混浊(2+)。双眼眼底均可见多灶性黄白色视网膜下浸润。对左眼进行诊断性玻璃体及视网膜下活检,发现大淋巴细胞CD-20阳性,确诊为PVRL。患者在2个月内双眼接受了12次玻璃体内甲氨蝶呤注射,之后病变完全消退。然而,5个月后,左眼出现特征性视网膜下病变,伴有血管周围渗出和视网膜出血,诊断为PVRL复发,表现为闭塞性视网膜血管炎。荧光素血管造影显示视网膜新生血管形成,为此进行了全视网膜光凝并重复玻璃体内注射甲氨蝶呤。
原发性玻璃体视网膜淋巴瘤极具伪装性,虽然罕见,但PVRL复发可表现为闭塞性视网膜血管炎伴继发性新生血管形成,从而延误诊断及后续治疗。